Tivic Health Systems, Inc. (TIVC)
Market Cap | 1.54M |
Revenue (ttm) | 957,000 |
Net Income (ttm) | -6.42M |
Shares Out | 6.18M |
EPS (ttm) | -1.95 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 839,344 |
Open | 0.258 |
Previous Close | 0.258 |
Day's Range | 0.244 - 0.279 |
52-Week Range | 0.220 - 3.210 |
Beta | 2.41 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 14, 2024 |
About TIVC
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, ... [Read more]
Financial Performance
In 2023, Tivic Health Systems's revenue was $1.18 million, a decrease of -36.09% compared to the previous year's $1.84 million. Losses were -$8.24 million, -18.34% less than in 2022.
Financial StatementsNews
Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-mont...
Tivic Health Systems, Inc. (TIVC) Q3 2024 Earnings Call Transcript
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Jennifer Ernst - Chief Executive Officer Operator Welcome to Tivic Health S...
Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been...
Tivic Health Validates European Patents in Great Britain, Germany, and France
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicinal devices, announced today that it has validate...
Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it will report financial re...
First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that the first study subject ...
Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that CEO Jennifer Ernst will pr...
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it has r...
Tivic Health Accelerates VNS Commercial Strategy Development
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it has partne...
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, is pleased to announce the ap...
Tivic Health Systems, Inc. (TIVC) Q2 2024 Earnings Call Transcript
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Jennifer Ernst - Chief Executive Officer Kimberly Bambach - Interim Chief Fin...
Tivic Reports Second Quarter 2024 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its second quarter 2...
Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will ...
ASM Global Continues Its Live Programming Growth Naming Industry Veteran Ralph Marchetta as Regional Vice President of Live Entertainment
LOS ANGELES--(BUSINESS WIRE)-- #ASMGlobal--ASM Global — the world's No. 1 development and full-service venue company — has named longtime executive Ralph Marchetta to regional vice president of live e...
Tivic Announces 2024 Annual Meeting of Stockholders
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the Virtual A...
Tivic Health Expands Intellectual Property Portfolio
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has r...
Tivic Health: Christina Valauri Appointed to Board of Directors
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, is pleased to welcome Christi...
ServiceNow debuts as a Leader in P&C Claims Management Systems report by independent research firm
SANTA CLARA, Calif.--(BUSINESS WIRE)--ServiceNow debuts as a Leader in P&C Claims Management Systems report by independent research firm.
Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today it has initia...
Tivic Health Systems, Inc. (TIVC) Q1 2024 Earnings Call Transcript
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q1 2024 Earnings Conference Call May 15, 2024 4:30 PM ET Company Participants Jennifer Ernst – Chief Executive Officer Kimberly Bambach – Interim Chief Financ...
Tivic Reports First Quarter 2024 Financial Results and Subsequent Events
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its first quarter 20...
Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will ...
Tivic Health Announces Closing of $4.0 Million Public Offering
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the closing of its p...
Tivic Health Announces Pricing of $4.0 Million Public Offering
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its p...
Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today the final res...